| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024629 |
| Receipt No. | R000028334 |
| Scientific Title | The effect of intravenous Ketamine for postoperative pain after laparoscopic cholecystectomy |
| Date of disclosure of the study information | 2016/10/31 |
| Last modified on | 2020/05/12 (Ver. 6) |
| Basic information | ||
| Public title | The effect of intravenous Ketamine for postoperative pain after laparoscopic cholecystectomy | |
| Acronym | The effect of Ketamine for postoperative pain | |
| Scientific Title | The effect of intravenous Ketamine for postoperative pain after laparoscopic cholecystectomy | |
| Scientific Title:Acronym | The effect of Ketamine for postoperative pain | |
| Region |
|
|
| Condition | ||
| Condition | Patients undergoing laparoscopic cholecystectomy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluating the effect of intravenous administration of Ketamine for postoperative pain in patients undergoing laparoscopic cholecystectomy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluating the postoperative pain by using Visual Analogue Scale (VAS). |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control group
Manage the general anesthesia by TIVA(Total intravenous anesthesia),using propofol,remifentanil,fentanyl. Control the effect cite fentanyl concentration within 1-1.5 ng/ml at the end of the anesthesia. |
|
| Interventions/Control_2 | Ketamine group
Manage the general anesthesia as the control group. In this intervention group, also administer Ketamine 0.5 mg/kg intravenously before incision. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Man and female with the age between 20 to 75 years old.
2) Patients undergoing laparoscopic cholecystectomy |
|||
| Key exclusion criteria | 1) Patients having cerebrovascular disease, hypertention(systolic blood pressure over 160mmHg, diastolic blood pressure over 100mmHg), elevated intracranial pressure, severe heart failure.
2) Past medical histroy of convulsion. 3) Pregnant woman and woman having the possibility of pregnancy. 4) Obese patients with BMI over 35. 5) Patients excluded by the judge of principal investigator. |
|||
| Target sample size | 24 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Metropolitan Police Hospital | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | |||||||
| Address | 4-22-1 Nakano, Nakano-ku,Tokyo,Japan | ||||||
| TEL | 03-5343-5611 | ||||||
| chikomae@sa2.so-net.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Metropolitan Police Hospital | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | |||||||
| Address | 4-22-1 Nakano, Nakano-ku,Tokyo,Japan | ||||||
| TEL | 03-5343-5611 | ||||||
| Homepage URL | |||||||
| chikomae@sa2.so-net.ne.jp | |||||||
| Sponsor | |
| Institute | Tokyo Metropolitan Police Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 27 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028334 |